1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Tolkatchev, D.
Ng, A.
Vranken, W.
Ni, F.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
39
2878
2886
10.1021/bi992130u
10715107
Design and solution structure of a well-folded stack of two beta-hairpins based on the amino-terminal fragment of human granulin A.
2000
10.2210/pdb1g26/pdb
pdb_00001g26
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
3393.955
GRANULIN A
N-TERMINAL DOMAIN (RESIDUES 1-31)
D1V, K3H, S9I, Q20P
1
syn
polymer
HGA
no
no
VVHCDMEVICPDGYTCCRLPSGAWGCCPFTQ
VVHCDMEVICPDGYTCCRLPSGAWGCCPFTQ
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_nmr_spectrometer
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2000-11-01
1
1
2008-04-27
1
2
2011-07-13
1
3
2021-11-03
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_spectrometer.model
_struct_ref_seq_dif.details
1QGM belongs to a family of granulin-like repeats
1FWO belongs to a family of granulin-like repeats
RCSB
Y
RCSB
2000-10-17
REL
REL
The peptide was chemically synthesized using standard Fmoc chemistry and oxidized by air in solution, Cys17 and Cys27 were blocked with S-acetamidomethyl groups (Acm)
sample
This structure was determined using standard 2D homonuclear techniques
structures with the least restraint violations
200
10
2D NOESY
2D NOESY
2D NOESY
2D NOESY
5.0
ambient
288
K
5.0
ambient
298
K
The structures are based on a total of 241 restraints, 174 are unambiguous NOE-derived distance constraints, 47 ambiguous NOE-derived distance constraints, 8 dihedral angle restraints, 10 distance restraints from hydrogen bonds, 2 distance restraints from disulfide bonds.
distance geometry and simulated annealing
0.5 mM HGA 1-31 (D1V, K3H, S9I, Q20P); 20 mM sodium acetate-d3, 10% D2O, 90% H2O
10% D2O, 90% H2O
0.5 mM HGA 1-31 (D1V, K3H, S9I, Q20P); 20 mM sodium acetate-d3, 100% D2O
100% D2O
Brunger
refinement
X-PLOR
3.1
Brunger
structure solution
X-PLOR
3.1
500
Bruker
AVANCE
500
Bruker
DRX
VAL
1
n
1
VAL
1
A
VAL
2
n
2
VAL
2
A
HIS
3
n
3
HIS
3
A
CYS
4
n
4
CYS
4
A
ASP
5
n
5
ASP
5
A
MET
6
n
6
MET
6
A
GLU
7
n
7
GLU
7
A
VAL
8
n
8
VAL
8
A
ILE
9
n
9
ILE
9
A
CYS
10
n
10
CYS
10
A
PRO
11
n
11
PRO
11
A
ASP
12
n
12
ASP
12
A
GLY
13
n
13
GLY
13
A
TYR
14
n
14
TYR
14
A
THR
15
n
15
THR
15
A
CYS
16
n
16
CYS
16
A
CYS
17
n
17
CYS
17
A
ARG
18
n
18
ARG
18
A
LEU
19
n
19
LEU
19
A
PRO
20
n
20
PRO
20
A
SER
21
n
21
SER
21
A
GLY
22
n
22
GLY
22
A
ALA
23
n
23
ALA
23
A
TRP
24
n
24
TRP
24
A
GLY
25
n
25
GLY
25
A
CYS
26
n
26
CYS
26
A
CYS
27
n
27
CYS
27
A
PRO
28
n
28
PRO
28
A
PHE
29
n
29
PHE
29
A
THR
30
n
30
THR
30
A
GLN
31
n
31
GLN
31
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
ASP
5
A
N
ASP
5
A
O
VAL
8
A
O
VAL
8
A
O
CYS
17
A
O
CYS
17
A
N
GLY
25
A
N
GLY
25
1
A
A
O
H
PRO
TYR
11
14
1.56
3
A
A
O
H
PRO
GLY
11
13
1.56
5
A
A
O
H
PRO
GLY
11
13
1.55
6
A
A
O
H
PRO
GLY
11
13
1.55
8
A
A
H
O
VAL
CYS
2
10
1.59
10
A
A
O
H
PRO
GLY
11
13
1.57
1
A
ARG
18
0.275
SIDE CHAIN
2
A
ARG
18
0.205
SIDE CHAIN
3
A
ARG
18
0.181
SIDE CHAIN
4
A
ARG
18
0.317
SIDE CHAIN
5
A
ARG
18
0.285
SIDE CHAIN
6
A
ARG
18
0.260
SIDE CHAIN
7
A
ARG
18
0.180
SIDE CHAIN
8
A
ARG
18
0.235
SIDE CHAIN
9
A
ARG
18
0.262
SIDE CHAIN
10
A
ARG
18
0.282
SIDE CHAIN
1
A
HIS
3
-51.59
89.77
1
A
ASP
5
177.90
-170.79
2
A
VAL
8
-167.19
119.62
2
A
ASP
12
54.12
-77.57
3
A
HIS
3
-46.05
106.67
3
A
ASP
5
-156.87
-139.71
3
A
PRO
11
-81.15
41.06
3
A
ASP
12
66.34
-57.97
3
A
PHE
29
-147.63
59.84
3
A
THR
30
-116.18
69.92
4
A
ASP
5
-168.88
-166.45
4
A
SER
21
-99.14
31.66
5
A
HIS
3
-59.07
82.32
5
A
GLU
7
-136.61
-33.16
5
A
PRO
11
-80.33
38.01
5
A
ASP
12
66.32
-56.33
5
A
PHE
29
-147.66
-45.42
6
A
ASP
5
-169.54
-80.08
6
A
MET
6
-146.15
-53.79
6
A
PRO
11
-78.59
43.14
6
A
ASP
12
65.05
-58.95
7
A
HIS
3
56.07
93.50
7
A
ASP
5
-163.40
-153.61
7
A
PRO
11
-80.25
38.84
7
A
ASP
12
66.69
138.19
7
A
PHE
29
-153.60
20.56
8
A
ASP
5
-145.46
-147.27
8
A
ASP
12
-48.86
-19.16
8
A
PRO
20
-80.01
41.58
8
A
SER
21
-168.33
30.05
8
A
THR
30
-143.26
37.65
9
A
ASP
5
-160.18
-134.10
9
A
GLU
7
-121.83
-60.92
9
A
PRO
11
-78.98
42.77
9
A
ASP
12
63.04
137.91
9
A
PHE
29
-158.53
53.74
10
A
VAL
2
-104.40
56.07
10
A
ASP
5
-146.54
-60.61
10
A
MET
6
-176.51
-36.03
10
A
PRO
11
-82.09
32.98
10
A
ASP
12
66.59
-56.31
THE SOLUTION STRUCTURE OF A WELL-FOLDED PEPTIDE BASED ON THE 31-RESIDUE AMINO-TERMINAL SUBDOMAIN OF HUMAN GRANULIN A
1
N
N
disulf
2.019
A
CYS
4
A
SG
CYS
4
1_555
A
CYS
16
A
SG
CYS
16
1_555
disulf
2.020
A
CYS
10
A
SG
CYS
10
1_555
A
CYS
26
A
SG
CYS
26
1_555
CYTOKINE
granulin/epithelin protein repeats, beta-hairpin stack, CYTOKINE
GRN_HUMAN
UNP
1
281
P28799
MWTLVSWVALTAGLVAGTRCPDGQFCPVACCLDPGGASYSCCRPLLDKWPTTLSRHLGGPCQVDAHCSAGHSCIFTVSGT
SSCCPFPEAVACGDGHHCCPRGFHCSADGRSCFQRSGNNSVGAIQCPDSQFECPDFSTCCVMVDGSWGCCPMPQASCCED
RVHCCPHGAFCDLVHTRCITPTGTHPLAKKLPAQRTNRAVALSSSVMCPDARSRCPDGSTCCELPSGKYGCCPMPNATCC
SDHLHCCPQDTVCDLIQSKCLSKENATTDLLTKLPAHTVGDVKCDMEVSCPDGYTCCRLQSGAWGCCPFTQAVCCEDHIH
CCPAGFTCDTQKGTCEQGPHQVPWMEKAPAHLSLPDPQALKRDVPCDNVSSCPSSDTCCQLTSGEWGCCPIPEAVCCSDH
QHCCPQGYTCVAEGQCQRGSEIVAGLEKMPARRASLSHPRDIGCDQHTSCPVGGTCCPSLGGSWACCQLPHAVCCEDRQH
CCPAGYTCNVKARSCEKEVVSAQPATFLARSPHVGVKDVECGEGHFCHDNQTCCRDNRQGWACCPYRQGVCCADRRHCCP
AGFRCAARGTKCLRREAPRWDAPLRDPALRQLL
281
311
1G26
1
31
P28799
A
1
1
31
1
ASP
engineered mutation
VAL
1
1G26
A
P28799
UNP
281
1
1
LYS
engineered mutation
HIS
3
1G26
A
P28799
UNP
283
3
1
SER
engineered mutation
ILE
9
1G26
A
P28799
UNP
289
9
1
GLN
engineered mutation
PRO
20
1G26
A
P28799
UNP
300
20
2
2
anti-parallel
anti-parallel
A
VAL
2
A
VAL
2
A
ASP
5
A
ASP
5
A
VAL
8
A
VAL
8
A
CYS
10
A
CYS
10
A
TYR
14
A
TYR
14
A
ARG
18
A
ARG
18
A
TRP
24
A
TRP
24
A
PRO
28
A
PRO
28
1
P 1